49 Wealth Management LLC Lowers Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

49 Wealth Management LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,535 shares of the exchange traded fund’s stock after selling 228 shares during the period. 49 Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $238,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of XBI. EP Wealth Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 132.1% in the third quarter. EP Wealth Advisors LLC now owns 20,786 shares of the exchange traded fund’s stock valued at $1,518,000 after purchasing an additional 11,832 shares during the last quarter. Headinvest LLC purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $85,000. Anchor Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $812,000. Doliver Advisors LP purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $215,000. Finally, Northside Capital Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 161.3% in the fourth quarter. Northside Capital Management LLC now owns 20,900 shares of the exchange traded fund’s stock valued at $1,866,000 after acquiring an additional 12,900 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.0 %

Shares of XBI traded up $1.00 on Friday, reaching $98.96. 9,005,856 shares of the company’s stock traded hands, compared to its average volume of 10,524,539. The stock’s 50 day simple moving average is $91.63 and its two-hundred day simple moving average is $91.36. The stock has a market cap of $7.54 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.